Promising positive liver targeting delivery system based on arabinogalactan-anchored polymeric micelles of norcantharidin
Source abstract
Abstract
Liver cancer is the third most common cause of global cancer-related deaths. This study focused on newly developed drug delivery systems with hepatocyte asialoglycoprotein receptor binding targeting the liver. Although norcantharidin (NCTD) is effective in primary liver cancer treatment, its toxicity in the urinary system remains. Positive liver-targeting effect could be achieved by preparing polymer micelles by arabinogalactan on the surface of N-(4-methylimidazole)-hydroxyethyl-chitosan (MHC). HepG2 cells were used to analyze the cytotoxicity, invasion, apoptosis and uptake of NCTD-loaded micelles. The in vivo antitumor efficacy of NCTD-M was evaluated using tumor-bearing nude mice. Successful preparation of NCTD-M was shown. In vivo imaging showed that micelles significantly increased positive liver drug targeting. Laser confocal microscopy showed increased cellular uptake of micelles. NCTD-M also enhanced cell invasion and the proportion of apoptotic cells. Compared with the other groups, the micelles showed better antitumor effects in vivo. Therefore, the positive liver-targeting NCTD-M, which can enhance antitumor efficacy and reduce toxicity, could be a promising and effective therapeutic agent for liver cancer treatment.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Beetle Biology and Toxicology Studies · Natural Compounds in Disease Treatment · Synthesis and bioactivity of alkaloids
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Nanjing University of Chinese Medicine
Jiangsu Provincial Academy of Traditional Chinese Medicine
Zhejiang Pharmaceutical College
Department of Oncology, Jining First People’s Hospital
Funding
National Natural Science Foundation of China · Natural Science Foundation of Shandong Province
References (32)
Show source-provided references
1. Fan YZ, Zhao ZM, Fu JY, et al. Norcantharidin inhibits growth of human gallbladder carcinoma xenografted tumors in nude mice by inducing apoptosis and blocking the cell cycle in vivo. Hepatobiliary Pancreat Dis Int. 2010;9:414–422.
2. 10.1177/153303461562458310.1177/1533034615624583 ↗
3. 10.3109/10717544.2013.84069210.3109/10717544.2013.840692 ↗
4. 10.21873/anticanres.1119210.21873/anticanres.11192 ↗
5. 10.1016/j.jep.2016.03.05810.1016/j.jep.2016.03.058 ↗
6. 10.1371/journal.pone.004495610.1371/journal.pone.0044956 ↗
7. 10.1080/1071754050017682910.1080/10717540500176829 ↗
8. Chen SF, Lu WF, Wen ZY, et al. Preparation, characterization and anticancer activity of norcantharidin-loaded poly(ethylene glycol)-poly (caprolactone) amphiphilic block copolymer micelles. Pharmazie. 2012;67:781–788.10.31083/ph.2012.1151 ↗
9. 10.1016/j.carbpol.2017.06.07210.1016/j.carbpol.2017.06.072 ↗
10. 10.1016/j.ijpharm.2014.07.04710.1016/j.ijpharm.2014.07.047 ↗
11. 10.1016/j.bmcl.2017.12.00410.1016/j.bmcl.2017.12.004 ↗
12. Zhang Y, Zhou T, Luo L, et al. Pharmacokinetics, biodistribution and receptor mediated endocytosis of a natural Angelica sinensis polysaccharide. Artif Cells Nanomed Biotechnol. 2018;24:1–10.
13. 10.1016/j.carres.2014.05.02210.1016/j.carres.2014.05.022 ↗
14. 10.1016/0730-725X(90)90143-P10.1016/0730-725X(90)90143-P ↗
15. 10.1208/s12248-013-9474-610.1208/s12248-013-9474-6 ↗
16. 10.1111/jphp.1244810.1111/jphp.12448 ↗
17. 10.1080/10717544.2017.139930510.1080/10717544.2017.1399305 ↗
18. 10.1166/jbn.2013.157210.1166/jbn.2013.1572 ↗
19. Xia XJ, Hu Y, Jin J, et al. Research on self-assembly micelles of N- (4-methylimidazole) -hydroxyethyl-chitosan loading quercetin. J China Pharm Univ. 2017;48:46–52.
20. 10.1002/smll.20170316410.1002/smll.201703164 ↗
21. 10.1080/10717544.2016.122585610.1080/10717544.2016.1225856 ↗
22. 10.1111/jphp.1259010.1111/jphp.12590 ↗
23. 10.2147/IJN.S14430510.2147/IJN.S144305 ↗
24. 10.1016/j.ijpharm.2013.05.05210.1016/j.ijpharm.2013.05.052 ↗
25. 10.1016/j.ijpharm.2016.08.04510.1016/j.ijpharm.2016.08.045 ↗
26. 10.1016/j.biomaterials.2012.09.02710.1016/j.biomaterials.2012.09.027 ↗
27. 10.1021/acs.molpharmaceut.7b0116410.1021/acs.molpharmaceut.7b01164 ↗
28. Cheng-Qian Y, Xin-Jing W, Wei X, et al. Lovastatin inhibited the growth of gastric cancer cells. Hepatogastroenterology 2014;61:1–4.
29. 10.1016/j.tiv.2010.11.00110.1016/j.tiv.2010.11.001 ↗
30. 10.1016/0959-8049(95)00050-X10.1016/0959-8049(95)00050-X ↗
31. 10.1016/j.carres.2015.03.00310.1016/j.carres.2015.03.003 ↗
32. 10.1074/jbc.M10178620010.1074/jbc.M101786200 ↗